Dendritic Cell-Based Vaccines for Cancer Therapy

This publication has 100 references indexed in Scilit:

• Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells
  The Journal of Experimental Medicine, 2002
• Lymphotactin cotransfection enhances the therapeutic efficacy of dendritic cells genetically modified with melanoma antigen gp100
  Gene Therapy, 2002
• A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection
  International Journal of Cancer, 2001
• Gene Therapy of Malignant Gliomas: A Pilot Study of Vaccination with Irradiated Autologous Glioma and Dendritic Cells Admixed with IL-4 Transduced Fibroblasts to Elicit an Immune Response
  Human Gene Therapy, 2001
• Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma
  International Journal of Cancer, 1999
• 6-C-kine (SLC), a Lymphocyte Adhesion-triggering Chemokine Expressed by High Endothelium, Is an Agonist for the MIP-3β Receptor CCR7
  The Journal of cell biology, 1998
• CpG motifs in bacterial DNA trigger direct B-cell activation
  Nature, 1995
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1994
• Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.
  The Journal of Experimental Medicine, 1992
• The Dendritic Cell System and its Role in Immunogenicity
  Annual Review of Immunology, 1991